United States · FDA National Drug Code directory
Loperamide HCl
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50844-735_cb21f56f-f513-4fa1-817c-0e5c3ce660c5
- Product NDC
- 50844-735
- Form
- TABLET
- Composition / generic term
- Loperamide HCl
- Labeler
- L.N.K. International, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20050503
- Source listing expiry
- 20261231
Source-listed ingredients
- LOPERAMIDE HYDROCHLORIDE — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 2 BLISTER PACK in 1 CARTON (50844-735-02) / 6 TABLET in 1 BLISTER PACK · 50844-735-02
- 4 BLISTER PACK in 1 CARTON (50844-735-08) / 6 TABLET in 1 BLISTER PACK · 50844-735-08
- 2 BLISTER PACK in 1 CARTON (50844-735-19) / 4 TABLET in 1 BLISTER PACK · 50844-735-19
- 1 BLISTER PACK in 1 CARTON (50844-735-24) / 2 TABLET in 1 BLISTER PACK · 50844-735-24
- 3 BLISTER PACK in 1 CARTON (50844-735-44) / 6 TABLET in 1 BLISTER PACK · 50844-735-44
- 1 BLISTER PACK in 1 CARTON (50844-735-45) / 6 TABLET in 1 BLISTER PACK · 50844-735-45
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →